Publications To Date


    Filter Publications

    PAGE 65 OF 87 | DISPLAYING 961 - 975 OF 1293 RESULTS

    Wuerstlein R. et. al., The WSG BCIST Study: A prospective multicenter decision impact study utilizing the Prosigna assay for adjuvant treatment decision-making in ER-positive, HER2-negative early-stage breast cancer., [Epub ahead of print]., Curr. Med. Res. Opin., Mar 14, 2016

    Schmid P. et al., Phase II Randomized Preoperative Window-of-Opportunity Study of the PI3K Inhibitor Pictilisib Plus Anastrozole Compared With Anastrozole Alone in Patients With Estrogen Receptor–Positive Breast Cancer, [Epub ahead of print]., J. Clin. Oncol., Mar 14, 2016

    Barry G.S. et al., Genomic markers of panitumumab resistance including ERBB2/ HER2 in a phase II study of KRAS wild-type (wt) metastatic colorectal cancer (mCRC)., [Epub ahead of print]., Oncotarget, Mar 09, 2016

    Dadiani M. et al., Tumor Evolution Inferred by Patterns of microRNA Expression through the Course of Disease, Therapy and Recurrence in Breast Cancer , [Epub ahead of print]., Clin. Can. Res., Mar 08, 2016

    D'Artista L. et al., Pin1 is required for sustained B cell proliferation upon oncogenic activation of Myc., [Epub ahead of print]., Oncotarget, Mar 02, 2016

    Zhou H. et al., Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism., [Epub ahead of print]., eLife, Feb 27, 2016

    Huang Y-H. et al., Delivery of Therapeutics Targeting the mRNA-Binding Protein HuR Using 3DNA Nanocarriers Suppresses Ovarian Tumor Growth., [Epub ahead of print]., Cancer Res., Feb 26, 2016

    Walter R.F.H. et. al., Folic-acid metabolism and DNA-repair phenotypes differ between neuroendocrine lung tumors and associate with aggressive subtypes, therapy resistance and outcome., [Epub ahead of print]., Oncotarget, Feb 26, 2016

    Walter R.F.H. et al., microRNAs are differentially regulated between MDM2-positive and negative malignant pleural mesothelioma., [Epub ahead of print]., Oncotarget, Feb 24, 2016

    Rooney C. et. al., Characterization of FGFR1 Locus in sqNSCLC Reveals a Broad and Heterogeneous Amplicon, [Epub ahead of print]., PLoS ONE, Feb 23, 2016

    Chen L. et al., A sensitive NanoString-based assay to score STK11 (LKB1) pathway disruption in lung adenocarcinoma, [Epub ahead of print]., J. Thoracic Surgery, Feb 23, 2016

    Kim J-Y. et al., Prognostic value of ERBB4 expression in patients with triple negative breast cancer., [Epub ahead of print]., BMC Cancer, Feb 22, 2016

    Vizuete W. et al., From the Field to the Laboratory: Air Pollutant-Induced Genomic Effects in Lung Cells, [Epub ahead of print]., Environ Health Insights, Feb 18, 2016

    Das K. et al., NanoString expression profiling identifies candidate biomarkers of RAD001 response in metastatic gastric cancer., [Epub ahead of print]., BMJ, Feb 17, 2016

    Dietl S. et al., MB3W1 is an orthotopic xenograft model for anaplastic medulloblastoma displaying cancer stem cell- and Group 3-properties., [Epub ahead of print]., BMC Cancer, Feb 17, 2016